Infection Control and Hospital Epidemiology Publication Info
For individual subscriptions, please contact the The University of Chicago Press
University of Chicago Press Customer Service:
1.877.705.1878 (toll-free, U.S. & Canada)
1.773.753.3347 (international)
subscriptions@press.uchicago.edu
For information about institutional access to this title, please visit the Institutional Subscriptions page.
The Case‐Case–Control Study Design: Addressing the Limitations of Risk Factor Studies for Antimicrobial Resistance
Formats Available in JSTOR: PDF
Abstract(back to top)
OBJECTIVE. There are significant limitations of the standard case–control study design for identifying risk factors for resistant organisms. The objective of this study was to develop a study design to overcome these limitations.
DESIGN. Theoretical analysis of different types of study designs that can be used in risk factor studies for resistant organisms.
RESULTS. We developed the case‐case–control study design, which uses two separate case–control analyses within a single study. The first analysis compares patients infected with resistant bacteria (resistant cases) with control‐patients without infection caused by the target organism, who are therefore representative of the source population; and the second analysis compares patients infected with the susceptible phenotype of the target organism (susceptible cases) with the same control‐patients without infection caused by the target organism. These two analyses provide risk models for (1) isolation of the resistant phenotype of the target organism as compared with the source population and (2) isolation of the susceptible phenotype of the organism as compared with the source population. When these two risk models are compared and contrasted, risk factors specifically associated with isolation of the resistant phenotype can be identified.
CONCLUSIONS. The case‐case–control study design is an effective method for identifying risk factors for antimicrobial‐resistant pathogens. Although the case‐case–control study design has limitations, it is, in our opinion, more informative and less flawed than the standard case–control study design.
Bibliographic Information(back to top)
- The Case‐Case–Control Study Design: Addressing the Limitations of Risk Factor Studies for Antimicrobial Resistance
- Keith S. Kaye , MD, MPH, Anthony D. Harris , MD, MPH, Matthew Samore , MD and Yehuda Carmeli , MD, MPH
- Infection Control and Hospital Epidemiology
- Vol. 26, No. 4 (April 2005) (pp. 346-351)
Notes and References(back to top)
This item contains 1 note(s).
Notes
Dr. Kaye is from the Department of Medicine, Duke University Medical Center, Durham, North Carolina. Dr. Harris is from the University of Maryland School of Medicine, College Park, and the Veterans Affairs Maryland Health Care System, Baltimore, Maryland. Dr. Samore is from the University of Utah, Salt Lake City, Utah. Dr. Carmeli is from the Tel Aviv Medical Center, Tel Aviv, Israel.Address reprint requests to Keith S. Kaye, MD, MPH, Box 3152, Durham, NC 27710. kaye0001@mc.duke.edu
Items Citing this Item (back to top)
5 item(s) in JSTOR cite this item
- Jason M. Pogue , PharmD; David L. Paterson , MD; A. William Pasculle , ScD; Brian A. Potoski , PharmDVol. 28, No. 12 (December 2007) pp. 1382-1388Stable URL: http://www.jstor.org/stable/10.1086/523276
- Jan E. Patterson , MDVol. 27, No. 9 (September 2006) pp. 889-892Stable URL: http://www.jstor.org/stable/10.1086/507436
- Brian A. Potoski, Jennifer Adams, Lloyd Clarke, Kathleen Shutt, Peter K. Linden, Carla Baxter, A. William Pasculle, Blair Capitano, Anton Y. Peleg, Dora Szabo, David L. PatersonVol. 43, No. 2 (Jul. 15, 2006) pp. 165-171Stable URL: http://www.jstor.org/stable/4484905
- Erika M. C. D’Agata , MD MPH; Maria Adriana Cataldo , MD; Roberto Cauda , MD; Evelina Tacconelli MDVol. 27, No. 7 (July 2006) pp. 670-674Stable URL: http://www.jstor.org/stable/10.1086/505917
- Erika M. C. D’Agata , MD, MPHVol. 26, No. 4 (April 2005) pp. 338-341Stable URL: http://www.jstor.org/stable/10.1086/502548